Advertisement
Advertisement
CMMB
Chemomab Therapeutics Ltd. - ADR
1.55
USDSponsored
+0.05
+3.33%
Jun 24, 14:52 UTC -4
Closed
Pre-Market
1.66
+0.11
+7.29%
CMMB Earnings Reports
Positive Surprise Ratio
CMMB beat 4 of 22 last estimates.
18%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.15
Implied change from Q1 26 (Revenue/ EPS)
--
/-37.50%
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Chemomab Therapeutics Ltd. - ADR earnings per share and revenue
On May 14, 2026, CMMB reported earnings of -0.24 USD per share (EPS) for Q1 26, missing the estimate of -0.15 USD, resulting in a -51.80% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.30% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.15 USD, with revenue projected to reach -- USD, implying an decrease of -37.50% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
What were Chemomab Therapeutics Ltd. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Chemomab Therapeutics Ltd. - ADR reported EPS of -$0.24, missing estimates by -51.8%, and revenue of $0.00, 0% as expectations.
How did the market react to Chemomab Therapeutics Ltd. - ADR's Q1 2026 earnings?
The stock price moved down -2.3%, changed from $1.74 before the earnings release to $1.70 the day after.
When is Chemomab Therapeutics Ltd. - ADR expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Chemomab Therapeutics Ltd. - ADR's next earnings report?
Based on 3
analysts, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.15 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement